Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Perico
G Remuzzi

Showing results (401-410 of 551) with videos related to

Pageof 56
Sort By:
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritisM Livio, D Macconi, M Morigi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1992
Defective platelet aggregation in response to platelet-activating factor in uremia associated with low platelet thromboxane A2 generationD Macconi, G ViganĂ², G Bisogno, et al.
Kidney International|January 6, 2006
ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal diseaseA Remuzzi, E Gagliardini, F Sangalli, et al.
American Journal of Obstetrics and Gynecology|March 1, 1991
Human placenta expresses endothelin gene and corresponding protein is excreted in urine in increasing amounts during normal pregnancyA Benigni, F Gaspari, S Orisio, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 29, 2000
ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndromeP Ruggenenti, L Mosconi, G Vendramin, et al.
Kidney International|August 1, 1993
A specific endothelin subtype A receptor antagonist protects against injury in renal disease progressionA Benigni, C Zoja, D Corna, et al.
Xenotransplantation|December 16, 1998
Xenogeneic human serum promotes leukocyte adhesion to porcine endothelium under flow conditions, possibly through the activation of the transcription factor NF-kappa BM Morigi, C Zoja, S Colleoni, et al.
The International Journal of Artificial Organs|March 1, 1980
Platelets from uraemic patients react normally to prostacyclinF Pusineri, E Gotti, G Remuzzi, et al.
Analytical Biochemistry|May 15, 1987
Antibody-mediated extraction/negative-ion chemical ionization mass spectrometric measurement of thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urineC Chiabrando, A Benigni, A Piccinelli, et al.
The American Journal of Medicine|April 1, 1979
Plasmapheresis in the treatment of acute renal failure in multiple myelomaR Misiani, G Remuzzi, T Bertani, et al.
Pageof 56

Showing results (401-410 of 551) with videos related to

Sort By:
Pageof 56
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1987
A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritisM Livio, D Macconi, M Morigi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1992
Defective platelet aggregation in response to platelet-activating factor in uremia associated with low platelet thromboxane A2 generationD Macconi, G ViganĂ², G Bisogno, et al.
Kidney International|January 6, 2006
ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal diseaseA Remuzzi, E Gagliardini, F Sangalli, et al.
American Journal of Obstetrics and Gynecology|March 1, 1991
Human placenta expresses endothelin gene and corresponding protein is excreted in urine in increasing amounts during normal pregnancyA Benigni, F Gaspari, S Orisio, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 29, 2000
ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndromeP Ruggenenti, L Mosconi, G Vendramin, et al.
Kidney International|August 1, 1993
A specific endothelin subtype A receptor antagonist protects against injury in renal disease progressionA Benigni, C Zoja, D Corna, et al.
Xenotransplantation|December 16, 1998
Xenogeneic human serum promotes leukocyte adhesion to porcine endothelium under flow conditions, possibly through the activation of the transcription factor NF-kappa BM Morigi, C Zoja, S Colleoni, et al.
The International Journal of Artificial Organs|March 1, 1980
Platelets from uraemic patients react normally to prostacyclinF Pusineri, E Gotti, G Remuzzi, et al.
Analytical Biochemistry|May 15, 1987
Antibody-mediated extraction/negative-ion chemical ionization mass spectrometric measurement of thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urineC Chiabrando, A Benigni, A Piccinelli, et al.
The American Journal of Medicine|April 1, 1979
Plasmapheresis in the treatment of acute renal failure in multiple myelomaR Misiani, G Remuzzi, T Bertani, et al.
Pageof 56